Although there is significant correlation between AML-MRC and “secondary-type” gene mutations, a high percentage of AML cases that carry “secondary-type” mutations are neither secondary AML (13) nor AML-MRC (23). The gene discussed is CD200; the disease is acute myeloid leukemia.